Quote:
Originally Posted by camiseta
I am not a HIV/AIDS researcher but I am currently running my own non-HIV related clinical drug trial for my PhD here in Sydney. And recruitment of patients to the trial is extremely difficult here. I can understand why researchers would target their research on populations that have a higher incidence of HIV infections so that they can obtain more robust data and make their research budgets stretch further.
It may be difficult to find people to test things on here but the thing is that the sex workers they use in Africa and Asia were sometimes negative in the beginning.
If you look up the nonoxynol-9 scandal and its promotion as a preventative chemical back up for condoms or in lube then you will understand. Nonoxynol-9 (N-9) is used more as a spermicide but because it destroys the membrane of the sperm cell...it also is known to destroy epithelial lining of both the vaginal wall and rectum and allows there to be less of a protective barrier, which is dangerous if there is a break in the condom or if the person is barebacking.
In fact latex allergies have in a way come from the addition of nonoxynol-9 to pre-lubricated condoms.
Africa is a very different situation but at the same time it is not. There are incidents of people actually using anti-lubricants to facilitate a more dry sex when it comes to hetero couples and that has allowed a lot of increased exposure to HIV in some ways. But the fact that the Americans and the Vatican are very much on a general level opposed to making condoms readily available in Africa and Southeast Asia and teaching the people how to practice safe sex is messed up. They would rather be spreading the word of Jesus than safety.
As for rising infection rates in Australia I think there may be a correlation between the rising infection rate and the rise of "Crystal" usage. It makes perfect sense because most of the new cases here are because of there having been no negotiated safety in the first place.